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The vacuolating cytotoxin and the cytotoxin-associated protein, encoded by vacA and cagA, respectively, are
important virulence determinants of Helicobacter pylori. Sixty-five H. pylori strains were isolated from dyspeptic
patients (19 with peptic ulcer disease, 43 with chronic gastritis, and 3 with gastric cancer) and studied for
differences in the vacA and cagA genes and their relationship to VacA and CagA expression, cytotoxin activity,
and the clinical outcome of infection. By PCR, fifty-four (83.1%) of 65 strains had the vacA signal sequence
genotype s1 and only 10 (15.4%) had the type s2. After primer modification, the vacA middle-region types m1
and m2 were detected in 24 (36.9%) and 41 (63.1%) strains, respectively. The combinations s1-m2 (31 [47.7%])
and s1-m1 (23 [35.4%]) occurred more frequently than s2-m2 (10 [15.4%]) (P 5 0.01). No strain with the
combination s2-m1 was found. All 19 patients with peptic ulcers harbored type s1 strains, in contrast to 32
(74.4%) of 43 patients with gastritis (P 5 0.02). The vacA genotype s1 was associated with the presence of cagA
(P < 0.0001), VacA expression (P < 0.0001), and cytotoxin activity (P 5 0.003). The cagA gene was detectable
in 48 (73.8%) of 65 isolates and present in 16 (84.2%) of 19 ulcer patients and 29 (67.4%) of 43 patients with
gastritis (P 5 0.17). The vacA genotypes of German H. pylori isolates are identical to those previously reported.
H. pylori strains of vacA type s1 are associated with the occurrence of peptic ulceration and the presence of cagA,
cytotoxin activity, and VacA expression.
Helicobacter pylori, a spiral-shaped, microaerophilic bacte-
rium that colonizes the stomach in humans has been identified
as the cause of chronic gastritis, peptic ulcer disease (PUD),
gastric cancer, and mucosa-associated lymphoid tissue lym-
phoma (15, 18, 25, 27). Once established, it may reside in the
gastric mucosa for years, possibly for the life of the host (21),
because the immunological defense mechanisms of the host
fail to eliminate it.
There are specific virulence determinants in H. pylori strains,
apart from immunological factors in the host, that influence
the clinical outcome of infection. Virulence factors found in a
subset of clinical isolates, such as the vacuolating cytotoxin
(VacA) and the cytotoxin-associated protein (CagA), have
been recently identified (4, 6, 11, 12, 16).
Only 50 to 65% of strains produce an 87-kDa cytotoxin that
induces vacuolation of HeLa or primary gastric epithelial cells
in vitro (4, 8, 12, 14, 16, 20). Infection with VacA-producing
strains is associated with the presence of PUD (5, 12, 13).
Recently, specific vacA genotypes, which are characterized by
differences in the signal sequence and middle-region of the
gene, have been identified in isolates obtained from U.S. sub-
jects (1, 2). The vacA signal sequence type s1, but not type s2,
was closely associated with in vitro cytotoxin activity, PUD, and
the presence of the cagA gene. It is unknown whether H. pylori
isolates from Europe have identical vacA genotypes or carry
vacA alleles different from strains isolated in the United States.
The cagA gene is present in about 60 to 70% of H. pylori
strains and encodes a high-molecular-weight protein (120 to
140 kDa) (4, 22). CagA-producing H. pylori strains have been
detected in patients with PUD more frequently than in patients
with chronic gastritis alone (4, 6, 10, 29). Sequencing of the
cagA gene in H. pylori revealed a region of internal duplica-
tions which may be responsible for CagA size heterogeneity
(4). However, no information is available on the influence on
the clinical outcome with respect to diversity at the cagA gene
level.
The objectives of this study were (i) to characterize the vacA
alleles and analyze differences in the cagA gene that are
present in German H. pylori strains and (ii) to correlate differ-
ences found within these genes with VacA and CagA protein
expression, in vitro cytotoxicity, and clinical outcome.
MATERIALS AND METHODS
Patients, biopsy sampling, and cultivation of H. pylori strains. Sixty-five H. py-
lori isolates from a consecutive series of patients with H. pylori infection under-
going upper gastrointestinal endoscopy and two reference strains, H. pylori 60190
(ATCC 49503) (cytotoxin producing, cagA1) and Tx30a (non-cytotoxin-produc-
ing, cagA negative) were used in this study (1, 16). Endoscopic and histological
diagnoses were recorded for all patients. An ulcer was defined as an excavated
mucosal break with a diameter of .5 mm. All patients gave informed consent to
biopsy sampling. The study was approved by the Ethics Committee of the Uni-
versity of Heidelberg. Gastric biopsy specimens obtained from the antrum of all
65 patients and additionally from the corpus of 6 patients were homogenized,
inoculated onto Columbia agar with 10% human blood and 10% horse serum,
and grown under microaerophilic conditions at 37°C for 3 days. Multiple bacte-
rial colonies were harvested from agar plates and frozen in Brucella broth con-
taining 30% glycerine at 270°C. Subsequent analyses were performed on strains
derived from the frozen stocks. All H. pylori isolates were positive for oxidase,
catalase, and urease. The strains were numbered, and all analyses were per-
formed without prior knowledge of the clinical diagnosis. Moreover, each anal-
ysis was performed by different investigators who were unaware of the other
results.
Preparation of samples for PCR amplification. Genomic DNA was initially
isolated from H. pylori cultures by phenol-chloroform-isoamylalcohol extraction
and ethanol precipitation according to standard protocols. Identical PCR results
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were obtained when supernatants from bacterial suspensions in sterile water
were directly amplified. Therefore, further analyses were performed without the
DNA isolation step.
PCR amplification and detection of amplified DNA products. For vacA, prim-
ers vac1F and vac1R were used to amplify the signal sequence region (Table 1)
(1). Amplification fragments of 201 and 228 bp were expected from genotype s1
and s2, respectively. The middle region of the vacA gene was analyzed with
primers vac3F and vac3R (for m1) and vac4F and vac4R (for m2), which am-
plified 388-bp fragments for m1 and 346-bp fragments for m2.
For the amplification of cagA sequences, two primer sets were used. The first
primer set, cag1 and cag3, amplified a fragment of 612 to 615 bp from the
hydrophilic region of cagA (Table 1) (4, 22). Primers cag2 and cag4 were derived
from a region of internal duplications (4) and amplified DNA with expected
fragment lengths of 450 and 558 bp (4, 22).
PCR amplification was performed as previously described (17), under the
following conditions: initial denaturation at 95°C for 3 min followed by 35 cycles
of denaturation at 95°C for 50 s, annealing and extension for 160 s, and final
extension at 72°C for 2 min. Annealing temperatures were set at 55°C for
vac1F-vac1R, at 60°C for vac3F-vac3R and vac4F-vac4R, and at 50°C for primers
cag1-cag3 and cag2-cag4. Negative and positive controls (DNA of strain H. pylori
60190) were assayed in each run. Thirty microliters of each PCR mixture was
subjected to gel electrophoresis on 5% polyacrylamide gels. Aliquots of the PCR
products obtained with primers vac1F-vac1R and cag2-cag4 underwent restric-
tion endonuclease digestion with NlaIII (New England Biolabs, Beverly, Mass.)
for 2 h at 37°C prior to electrophoresis.
The PCR products obtained from amplification with primers cag2 and cag4
were hybridized with the probe hyb1 (59 GATAAAGTTGATGATCTCAG 39),
which identified the complete amplification product in undigested samples and
fragments of 102 and 143 bp in NlaIII-treated samples. Hybridization was per-
formed as previously described (17), except that hybridization and washing tem-
peratures were set at 56°C.
SDS-PAGE and Western blot analysis. Gel electrophoresis and Western blot-
ting were performed as previously described (19). In brief, supernatants of
whole-cell sonicates, containing 10 mg of protein, from each strain were sepa-
rated by sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-
PAGE). After transfer to a nitrocellulose membrane, the membrane was blocked
with low-fat skim milk and fetal calf serum in phosphate-buffered saline and
incubated with a 1:10,000 dilution of rabbit antisera to VacA and to CagA (kindly
provided by T. L. Cover, Nashville, Tenn., and by A. Covacci, Siena, Italy). An-
tiserum to VacA had been produced by immunizing rabbits with native VacA
enriched in supernatant preparations from H. pylori 60190 (6). Rabbit antiserum
to CagA was derived from a recombinant fusion protein obtained by subcloning
a DNA fragment of cagA into the expression vector pEx34b (28). The membrane
was incubated with alkaline phosphatase-conjugated goat anti-rabbit immuno-
globulin G antibody (dilution, 1:10,000) and then with enhanced chemilumines-
cence detection reagents (Western Light Chemilumiscent Detection System;
Tropix, Bedford, Mass.) and exposed to highly sensitive X-ray films for 30 min.
Cytotoxicity assay on HeLa cells. HeLa cells were cultured in plastic flasks
containing Dulbecco’s modified Eagle’s medium with 25 mM HEPES buffer (pH
7.2), 5% fetal calf serum, and 2 mM glutamine at 37°C in a 5% CO2 atmosphere.
Cells were seeded in 12-well plates at a concentration of 105 cells per well.
H. pylori was cultured for 3 days at 37°C in 20% brain heart infusion, 70% RPMI,
and 10% fetal calf serum in a gyratory water bath set under a microaerophilic
atmosphere. Supernatants (final optical density at 550 nm, 0.6) were prepared by
centrifugation (16,000 3 g at 4°C) and filtration through a 0.2-mm-pore-size
cellulose filter (12). The culture supernatants were diluted 1:1 with medium and
incubated with HeLa cells for 24 h. Culture medium was supplemented with 10
mM ammonium chloride to potentiate cytotoxin activity (9). Vacuolation was
assessed by light microscopy after staining with neutral red (7). Cytotoxicity was
defined as positive if vacuolation was observed in more than 20% of cells.
Statistical methods. Analysis of data was performed by using the x2 test with
Yates’ correction and Fisher’s exact test. Probability levels (P) of ,0.05 were
considered statistically significant.
RESULTS
Strain collection. Sixty-five strains were isolated from H. py-
lori-positive patients with dyspeptic symptoms. Endoscopic and
histological examination revealed gastritis in 43 patients, PUD
in 19 patients (9 with gastric ulcers of the antrum and 10 with
duodenal ulcers), and gastric adenocarcinoma in 3 patients. In
all patients with gastric ulcers, moderate to severe antral pre-
dominant chronic gastritis was diagnosed histologically. Pa-
tients with duodenal ulcers presented with duodenitis and, in
some cases, with chronic antral gastritis. In six patients, two
isolates were obtained from the antrum and the corpus. For
each of these patients, both isolates showed identical features
by PCR, Southern blotting, and Western blot analysis.
Determination of vacA genotypes and relationship to gastro-
intestinal disease. The vacA gene was detectable in all H. pylori
isolates. By using the primers vac1F and vac1R to amplify the
vacA signal sequences, the predicted PCR products of either
201 or 228 bp were obtained from 64 (98.5%) of 65 isolates.
Fifty-four (83.1%) of 65 strains yielded the smaller product,
representing genotype s1, and 10 (15.4%) yielded the larger
product, representing genotype s2. None of the strains yielded
a PCR product of any other size. All amplicons from genotype
s1 but none of the amplicons from genotype s2 were cut by
NlaIII into fragments of a predicted size of 94 and 107 bp (Fig.
1).
All 65 H. pylori strains and the two reference strains con-
tained DNA which was amplified either by the primers vac3F
and vac3R, representing type m1, or by the primers vac4F and
TABLE 1. Oligonucleotide primers used for typing of H. pylori vacA and cagA genes
Gene Region amplified Primer designation Primer sequence PCR product size (location)
vacA s1a vac1F 59 GAAATACAACAAACACACCGC 39 201 (800–1000b)
vac1R 59 GGCTTGTTTGAGCCCCCAG 39
s2a vac1F 59 GAAATACAACAAACACACCGC 39 228 (349–576c)
vac1R 59 GGCTTGTTTGAGCCCCCAG 39
m1 vac3F 59 GGTCAAAATGCGGTCATGG 39 388 (2741–3128b)
vac3R 59 CATCAGTATTTCGCACCACA 39
m2 vac4F 59 CCAGGAAACATTGCCGGCAAA 39 346 (2290–2635c)
vac4R 59 CATAACTAGCGCCTTGCAC 39
cagA Hydrophilic region cag1 59 GGAATTGTCTGATAAACTTG 39 615 (2577–3191d)
cag3 59 CCATTATTGTTATTGTTATTG 39 612 (3114–3725e)
Region of internal duplications cag2 59 GGAACCCTAGTCGGTAATG 39 450 (3070–3519d)
cag4 59 ATCTTTGAGCTTGTCTATCG 39 558 (3604–4161e)
a PCR products of regions s1 and s2 were differentiated on the basis of molecular size and restriction endonuclease digestion with NlaIII.
b Location in published vacA sequence of strain 60190 (8).
c Location in strain Tx30a (GenBank accession no. U29401).
d Location in published cagA sequence of strain CCUG 17874 (4).
e Location in published cagA sequence of strain ATCC 53726 (22).
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vac4R, specific for type m2 (Fig. 2). Twenty-four (36.9%) iso-
lates were classified as type m1, and 41 (63.1%) were classified
as type m2. None had DNA amplified by both primer sets or
gave PCR products of sizes other than those predicted. Among
the 65 isolates studied, vacA homologs containing three of the
four possible combinations of signal sequence and middle-
region types were identified. The s1-m1 and s1-m2 combina-
tions were found in 23 (35.4%) and 31 (47.7%) strains, respec-
tively, and the s2-m2 combination was identified in 10 (15.4%)
of 65 isolates. The s2-m1 combination was not detectable (P 5
0.01).
Infection with a type s1 strain was found in all 19 (100%)
patients with PUD, compared with 32 (74.4%) of 43 subjects
with gastritis (P 5 0.02). All type s2 strains were isolated from
patients with gastritis. The distribution of type s1-m1 and type
s1-m2 strains was similar in patients with PUD (s1-m1, 8;
s1-m2, 11) and gastritis (s1-m1, 13; s1-m2, 19), indicating that
the vacA middle region types were not independently associ-
ated with the occurrence of PUD.
Prevalence and size variation of the cagA gene in H. pylori
isolates. Forty-eight (73.8%) of 65 strains were cagA1. In 47 of
48 isolates and in reference strain H. pylori 60190, PCR prod-
ucts were obtained with both cagA primer sets (Fig. 3). One
strain showed an amplicon only with the primer set cag2-cag4
but not with the primer set cag1-cag3. Sixteen (84.2%) of 19
strains isolated from patients with PUD but only 29 (67.4%) of
43 isolates obtained from patients with gastritis carried the
cagA gene (P 5 0.17). All three isolates from patients with
gastric cancer were cagA1.
The PCR products of cagA1 strains obtained with primer set
cag2-cag4 differed in size, varying from 450 bp in 8 isolates,
including H. pylori 60190, to 552 to 558 bp in 22 isolates and
654 to 660 bp in 16 isolates (Fig. 4). NlaIII digestion of the
450-bp product resulted in DNA fragments of 307 to 313 bp
and 143 bp. In addition, a fragment of 102 bp was obtained
with PCR products of 552 to 558 bp and 654 to 660 bp after
NlaIII digestion. Southern blotting with the probe hyb1 iden-
tified all fragments of 143 and 102 bp, if present. cagA PCR
fragments of 450 bp or 552 to 558 bp were found more fre-
quently in H. pylori strains isolated from patients with PUD (14
of 16 [87.5%]) than in those from patients with only gastritis
(15 of 29 [51.7%]; P 5 0.012).
Relationship between vacA genotypes and presence of cagA
gene. Forty-seven (87.0%) of 54 vacA type s1 strains were
cagA1 (P , 0.0001). Of the 48 cagA1 strains, 47 (97.9%) were
found to have the vacA genotype s1. The signal sequence type
could not be determined in one cagA1 strain. None of the 10
type s2 strains carried the cagA gene. No association was found
between vacA middle-region type and cagA status.
Relationship between vacA genotype or cagA gene and pro-
tein expression and cytotoxin activity. By SDS-PAGE, super-
natants of whole-cell sonicates showed the CagA protein band,
varying between 120 and 140 kDa, which was recognized by
immunoblotting with CagA antiserum in 35 (85.4%) of 41
cagA1 H. pylori strains. In cagA mutant strains, only 1 (5.9%)
of 17 isolates was positive by immunoblotting (P , 0.0001).
VacA protein was detected by VacA antiserum in 44 (75.9%)
of 58 H. pylori isolates. Forty-one (87.2%) of 47 strains with the
FIG. 1. PAGE after PCR amplification of H. pylori DNA using primers
vac1F-vac1R and NlaIII digestion. Only DNA amplicons obtained with vacA
genotype s1 are cut by NlaIII into fragments of 107 and 94 bp. Lanes: M, 100-bp
DNA marker; 1, strain H. pylori 60190 (vacA genotype s1); 2, Tx30a (vacA
genotype s2); 3 to 8, type s1 isolates; 9 to 11, type s2 isolates. (The photographs
in this and subsequent figures were scanned with a Hewlett-Packard Scan Jet 4c
using the PaperPort Software Version 3.0.1 for Windows [Visioneer Communi-
cations, Inc.])
FIG. 2. PAGE after PCR amplification of H. pylori DNA using primers
vac3F-vac3R (a) and vac4F-vac4R (b). Lanes: M, 100-bp DNA marker; 1 to 11,
H. pylori strains as described in the legend to Fig. 1.
FIG. 3. PAGE after PCR amplification of H. pylori DNA using primers
cag1-cag3. Lanes: M, 100-bp DNA marker; 1 to 11, H. pylori strains as described
in the legend to Fig. 1.
FIG. 4. PAGE after PCR amplification of H. pylori DNA using primers
cag2-cag4. Lanes: M, 100-bp DNA marker; 1 to 11, H. pylori strains as described
in the legend to Fig. 1. Note the size variation of DNA amplicons of different
H. pylori strains.
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genotype s1 were detected by VacA antiserum. In contrast,
only 3 (30%) of 10 strains with vacA type s2 showed a weak
protein band by Western blotting (P , 0.0001).
Of the 58 H. pylori strains tested, supernatants from 34
(58.6%) induced vacuolation of HeLa cells (Tox1). Seventeen
(81.0%) of 21 strains with the vacA genotype s1-m1 and 16
(61.9%) of 26 strains with s1-m2 genotype were Tox1. In con-
trast, only 1 (10%) of 10 strains with the genotype s2-m2
induced a weak vacuolation in HeLa cells. Thus, strains pos-
sessing the vacA type s1 (33 of 47 [70.2%]) were more fre-
quently associated with vacuolating cytotoxicity than s2 type
strains (P 5 0.001). Although H. pylori strains isolated from
patients with PUD were more likely to be Tox1 (13 of 17
[76.5%]) than those obtained from patients with gastritis only
(21 of 37 [56.8%]), the differences were not significant (P 5
0.16). Twenty-seven (67.5%) of 40 cagA1 strains and 8 (47.1%)
of 17 cagA-negative strains induced vacuolation in HeLa cells
(P 5 0.147), demonstrating that cagA is not associated with
cytotoxin activity.
DISCUSSION
In this study, new oligonucleotide primers were established
to characterize the vacA genotypes in a consecutive series of
isolated H. pylori strains. Using these primers, the vacA geno-
types s1 and s2 were identified in all but one of the H. pylori
strains. In addition, restriction endonuclease digestion with
NlaIII allowed definitive differentiation of genotypes s1 and s2
by cutting only the PCR product of type s1. For determination
of the vacA middle-region genotypes, the published oligo-
nucleotide primers vac3R and vac4F were modified, because
computer-assisted alignment of the various vacA sequences of
European H. pylori strains deposited in the GenBank database
revealed single base exchanges at the locations of the original
primers (1). Therefore, primer sequences with complete iden-
tity next to these locations were selected. By using these prim-
ers for PCR, reliable classification of the vacA middle-region
genotype was possible in all H. pylori strains. In contrast, use of
the originally described primers (1) allowed characterization of
middle-region types in only 70% of the H. pylori strains isolated
from German patients (18a). This suggests that the mosaicism
of the vacA gene described for H. pylori strains from the United
States is also found in German H. pylori isolates. However,
regional variation in the vacA gene may occur due to the
enormous heterogeneity of H. pylori, which would thus require
modification of the oligonucleotide primers to characterize the
vacA alleles in European H. pylori strains.
H. pylori strains with the vacA signal sequence type s1 were
predominant in the series of German H. pylori isolates, where-
as strains with type s2 rarely occurred. However, the percent-
age of strains with the vacA genotype s2 may have been un-
derestimated, since the strains investigated in this study were
obtained from dyspeptic patients. Cytotoxic H. pylori strains
with vacA genotype s1 may occur more frequently in such pa-
tients. vacA genotype s1 was strongly associated with the pres-
ence of cagA and was more frequent in patients with PUD (1,
2). The difference between vacA type s2 and type s1 leader
sequences is generated by small inserts totaling 27 bp (1). It has
been hypothesized that strains with vacA genotype s2 lack
effective secretion of VacA through the cytoplasmic membrane
of the bacteria (1, 20). Alternatively, differences in the N-
terminal residues of the secreted VacA protein, arising from
different signal sequence cleavage sites in VacA for type s1 and
type s2, may be responsible for differences in protein function
(1). In contrast to strains with vacA type s1, type s2 isolates
express the VacA protein only in small amounts (1). This ex-
plains why almost all isolates with the vacA type s1 but only 3
of 10 type s2 strains had VacA detectable by immunoblot.
Furthermore, cytotoxin activity was observed almost exclu-
sively in type s1 strains. Only one type s2 strain showed weak
vacuolation of HeLa cells. However, some strains with geno-
type s1 and lower cytotoxin activity may not have been identi-
fied because of the use of nonconcentrated broth culture su-
pernatants for vacuolation testing (12).
Subgroup analysis demonstrated that the vacA middle-re-
gion type was not independently associated with the clinical
outcome of H. pylori infection, the presence of cagA, or de-
tectable cytotoxin activity. Almost half of the strains contained
the combination s1-m2, a finding which is different from the
results found in the United States (1), where the genotypes
s1-m1 and s2-m2 are more common. The vacA genotype s2-m1
was not found, suggesting that strains with this genotype suffer
from a selective disadvantage or are not viable.
About 74% of all isolates were cagA1 by PCR, which is in
agreement with the results of other studies from Europe (10,
26, 28, 29). The majority of the patients with PUD (84%) were
infected with cagA1 strains in contrast to strains isolated from
patients with gastritis only, in whom 67% of the H. pylori
strains were cagA1 (11, 26, 28). By PCR, size variations of the
cagA gene were found within the various H. pylori strains. This
may account for the size heterogeneity of CagA detected by
immunoblot in recent studies (4, 26, 29). Restriction endonu-
clease analysis and Southern blotting suggested that these size
variations may have been generated by a variable number of
internal repeat units located downstream of nucleotide 3406 of
the gene (4). Unexpectedly, the fragment length of this region
of cagA after PCR was found to be shorter in strains isolated
from patients with PUD than in those from patients with gas-
tritis alone. It is unclear whether these differences in the cagA
gene actually effect the clinical outcome of H. pylori infection
or whether these results are incidental. The exact role of the
cagA gene, which codes for the highly immunogenic CagA
protein, is not known. The cagA gene represents a putative
virulence marker and is included in the cag pathogenicity is-
land, a 40-kb segment with several genes, including picA and
picB, involved in cytokine induction (3, 24). It is conceivable
that size variation of CagA could affect its antigenic properties
and thereby alter the host’s immune system’s ability to recog-
nize the antigen.
The presence of the cagA gene was correlated with the
expression of CagA protein as determined by immunoblotting
(29). However, cagA was not associated with cytotoxicity in
HeLa cells and only 68% of cagA1 strains were cytotoxin
positive. These results are consistent with other reports that
cytotoxin production is derived from the vacA gene but not
from the cagA gene (23, 26).
In conclusion, the vacA genotypes in German H. pylori
strains were identical to those previously reported and could be
characterized by PCR after modification of the reported oli-
gonucleotide primers. H. pylori strains with the vacA signal
sequence type s1 and middle-region allele m2 were predomi-
nant in German H. pylori isolates. All combinations of these
vacA alleles occurred, with the exception of s2-m1. Type s1
strains were associated with peptic ulceration, presence of the
cagA gene, VacA expression, and cytotoxin activity. Size vari-
ations in a distinct region of cagA are common, but their
significance for clinical outcome needs further evaluation. The
findings suggest that cagA1 H. pylori strains with the vacA
genotype s1 increase the risk for PUD. Thus, vacA genotyping
may allow identification of infected subjects at different risk
levels.
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